Literature DB >> 24096958

Heterologous expression of natural product biosynthetic gene clusters in Streptomyces coelicolor: from genome mining to manipulation of biosynthetic pathways.

Juan Pablo Gomez-Escribano1, Mervyn J Bibb.   

Abstract

Heterologous gene expression is one of the main strategies used to access the full biosynthetic potential of actinomycetes, as well as to study the metabolic pathways of natural product biosynthesis and to create unnatural pathways. Streptomyces coelicolor A3(2) is the most studied member of the actinomycetes, bacteria renowned for their prolific capacity to synthesize a wide range of biologically active specialized metabolites. We review here the use of strains of this species for the heterologous production of structurally diverse actinomycete natural products.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24096958     DOI: 10.1007/s10295-013-1348-5

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  61 in total

Review 1.  Thoughts and facts about antibiotics: where we are now and where we are heading.

Authors:  János Bérdy
Journal:  J Antibiot (Tokyo)       Date:  2012-04-18       Impact factor: 2.649

2.  Deletion of a regulatory gene within the cpk gene cluster reveals novel antibacterial activity in Streptomyces coelicolor A3(2).

Authors:  Marco Gottelt; Stefan Kol; Juan Pablo Gomez-Escribano; Mervyn Bibb; Eriko Takano
Journal:  Microbiology (Reading)       Date:  2010-05-06       Impact factor: 2.777

3.  Codon usage in the G+C-rich Streptomyces genome.

Authors:  F Wright; M J Bibb
Journal:  Gene       Date:  1992-04-01       Impact factor: 3.688

Review 4.  Genomic basis for natural product biosynthetic diversity in the actinomycetes.

Authors:  Markus Nett; Haruo Ikeda; Bradley S Moore
Journal:  Nat Prod Rep       Date:  2009-09-01       Impact factor: 13.423

5.  afsR is a pleiotropic but conditionally required regulatory gene for antibiotic production in Streptomyces coelicolor A3(2).

Authors:  B Floriano; M Bibb
Journal:  Mol Microbiol       Date:  1996-07       Impact factor: 3.501

6.  Chemical characterisation of disruptants of the Streptomyces coelicolor A3(2) actVI genes involved in actinorhodin biosynthesis.

Authors:  T Taguchi; K Itou; Y Ebizuka; F Malpartida; D A Hopwood; C M Surti; K I Booker-Milburn; G R Stephenson; K Ichinose
Journal:  J Antibiot (Tokyo)       Date:  2000-02       Impact factor: 2.649

7.  Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens.

Authors:  Luisa Laureti; Lijiang Song; Sheng Huang; Christophe Corre; Pierre Leblond; Gregory L Challis; Bertrand Aigle
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

8.  Discovery of a new peptide natural product by Streptomyces coelicolor genome mining.

Authors:  Sylvie Lautru; Robert J Deeth; Lianne M Bailey; Gregory L Challis
Journal:  Nat Chem Biol       Date:  2005-09-11       Impact factor: 15.040

Review 9.  New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters.

Authors:  Kozo Ochi; Takeshi Hosaka
Journal:  Appl Microbiol Biotechnol       Date:  2012-11-11       Impact factor: 4.813

10.  Robust, small-scale cultivation platform for Streptomyces coelicolor.

Authors:  Sujata Vijay Sohoni; Prashant Madhusudan Bapat; Anna Eliasson Lantz
Journal:  Microb Cell Fact       Date:  2012-01-17       Impact factor: 5.328

View more
  46 in total

Review 1.  Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.

Authors:  Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2015-09-12       Impact factor: 3.346

Review 2.  Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?

Authors:  Yuriy Rebets; Elke Brötz; Bogdan Tokovenko; Andriy Luzhetskyy
Journal:  J Ind Microbiol Biotechnol       Date:  2013-10-15       Impact factor: 3.346

3.  MbtH homology codes to identify gifted microbes for genome mining.

Authors:  Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2013-11-07       Impact factor: 3.346

Review 4.  Metagenomics Approaches in Discovery and Development of New Bioactive Compounds from Marine Actinomycetes.

Authors:  Gyana Prakash Mahapatra; Surabhi Raman; Suman Nayak; Sushanto Gouda; Gitishree Das; Jayanta Kumar Patra
Journal:  Curr Microbiol       Date:  2019-05-08       Impact factor: 2.188

Review 5.  Insights into microbial cryptic gene activation and strain improvement: principle, application and technical aspects.

Authors:  Kozo Ochi
Journal:  J Antibiot (Tokyo)       Date:  2016-07-06       Impact factor: 2.649

Review 6.  Streptomycetes: Surrogate hosts for the genetic manipulation of biosynthetic gene clusters and production of natural products.

Authors:  Keshav K Nepal; Guojun Wang
Journal:  Biotechnol Adv       Date:  2018-10-09       Impact factor: 14.227

7.  Lincomycin at Subinhibitory Concentrations Potentiates Secondary Metabolite Production by Streptomyces spp.

Authors:  Yu Imai; Seizo Sato; Yukinori Tanaka; Kozo Ochi; Takeshi Hosaka
Journal:  Appl Environ Microbiol       Date:  2015-03-27       Impact factor: 4.792

8.  Bioprospecting of Novel and Bioactive Compounds from Marine Actinomycetes Isolated from South China Sea Sediments.

Authors:  Na Yang; Fuhang Song
Journal:  Curr Microbiol       Date:  2017-09-16       Impact factor: 2.188

Review 9.  Comparative mass spectrometry-based metabolomics strategies for the investigation of microbial secondary metabolites.

Authors:  Brett C Covington; John A McLean; Brian O Bachmann
Journal:  Nat Prod Rep       Date:  2017-01-04       Impact factor: 13.423

10.  Refactoring the Cryptic Streptophenazine Biosynthetic Gene Cluster Unites Phenazine, Polyketide, and Nonribosomal Peptide Biochemistry.

Authors:  Katherine D Bauman; Jie Li; Kazuya Murata; Simone M Mantovani; Samira Dahesh; Victor Nizet; Hanna Luhavaya; Bradley S Moore
Journal:  Cell Chem Biol       Date:  2019-03-07       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.